Annual Revenue
$1.27 M
-$22.01 M-94.52%
December 1, 2024
Summary
- As of March 10, 2025, CDTX annual revenue is $1.27 million, with the most recent change of -$22.01 million (-94.52%) on December 1, 2024.
- During the last 3 years, CDTX annual revenue has fallen by -$48.30 million (-97.43%).
- CDTX annual revenue is now -98.02% below its all-time high of $64.45 million, reached on December 31, 2022.
Performance
CDTX Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Revenue
N/A
December 1, 2024
Summary
- CDTX quarterly revenue is not available.
Performance
CDTX Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Related metrics
TTM Revenue
N/A
December 1, 2024
Summary
- CDTX TTM revenue is not available.
Performance
CDTX TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
CDTX Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -94.5% | - | - |
| 3 y3 years | -97.4% | - | - |
| 5 y5 years | -93.9% | - | - |
CDTX Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -98.0% | at low | ||||
| 5 y | 5-year | -98.0% | at low | ||||
| alltime | all time | -98.0% | at low |
Cidara Therapeutics Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $1.27 M(-94.5%) | - | - |
| Jun 2024 | - | $302.00 K(-96.4%) | $20.74 M(-18.8%) |
| Mar 2024 | - | $8.46 M(+207.1%) | $25.53 M(-40.9%) |
| Dec 2023 | $23.28 M(-63.9%) | $2.76 M(-70.1%) | $43.17 M(-15.0%) |
| Sep 2023 | - | $9.22 M(+81.1%) | $50.79 M(-38.3%) |
| Jun 2023 | - | $5.09 M(-80.5%) | $82.32 M(-1.3%) |
| Mar 2023 | - | $26.11 M(+151.5%) | $83.45 M(+29.5%) |
| Dec 2022 | $64.45 M | $10.38 M(-74.5%) | $64.45 M(+5.1%) |
| Sep 2022 | - | $40.74 M(+555.5%) | $61.29 M(+121.9%) |
| Jun 2022 | - | $6.22 M(-12.6%) | $27.63 M(-49.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $7.11 M(-1.6%) | $54.27 M(+9.5%) |
| Dec 2021 | $49.57 M(+310.8%) | $7.22 M(+2.1%) | $49.57 M(+7.6%) |
| Sep 2021 | - | $7.08 M(-78.5%) | $46.08 M(+11.3%) |
| Jun 2021 | - | $32.86 M(+1264.7%) | $41.42 M(+246.7%) |
| Mar 2021 | - | $2.41 M(-35.4%) | $11.95 M(-1.0%) |
| Dec 2020 | $12.07 M(-42.3%) | $3.73 M(+54.3%) | $12.07 M(+18.9%) |
| Sep 2020 | - | $2.42 M(-28.8%) | $10.15 M(-62.2%) |
| Jun 2020 | - | $3.39 M(+34.1%) | $26.84 M(+14.5%) |
| Mar 2020 | - | $2.53 M(+39.4%) | $23.45 M(+12.1%) |
| Dec 2019 | $20.91 M | $1.81 M(-90.5%) | $20.91 M(+9.5%) |
| Sep 2019 | - | $19.10 M | $19.10 M |
FAQ
- What is Cidara Therapeutics annual revenue?
- What is the all time high annual revenue for Cidara Therapeutics?
- What is Cidara Therapeutics annual revenue year-on-year change?
- What is the all time high quarterly revenue for Cidara Therapeutics?
- What is the all time high TTM revenue for Cidara Therapeutics?
What is Cidara Therapeutics annual revenue?
The current annual revenue of CDTX is $1.27 M
What is the all time high annual revenue for Cidara Therapeutics?
Cidara Therapeutics all-time high annual revenue is $64.45 M
What is Cidara Therapeutics annual revenue year-on-year change?
Over the past year, CDTX annual revenue has changed by -$22.01 M (-94.52%)
What is the all time high quarterly revenue for Cidara Therapeutics?
Cidara Therapeutics all-time high quarterly revenue is $40.74 M
What is the all time high TTM revenue for Cidara Therapeutics?
Cidara Therapeutics all-time high TTM revenue is $83.45 M